Clinical trials
Phase 2 Purpura, Thrombocytopenic, Idiopathic trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
65 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 3 |
| 2019 | 1 |
| 2020 | 5 |
| 2021 | 6 |
| 2022 | 9 |
| 2023 | 12 |
| 2024 | 8 |
| 2025 | 7 |
| 2026 | 9 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 24 |
| Recruiting | 21 |
| Completed | 8 |
| Active, not recruiting | 5 |
| Not yet recruiting | 5 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peking University People's Hospital | 28 |
| Institute of Hematology & Blood Diseases Hospital, China | 20 |
| Shandong University | 7 |
| Peking Union Medical College Hospital | 2 |
| Beijing InnoCare Pharma Tech Co., Ltd. | 1 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 1 |
| Dizal Pharmaceuticals | 1 |
| Hangzhou Sumgen Biotech Co., Ltd. | 1 |
| Keymed Biosciences Co.Ltd | 1 |
| Novartis Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Purpura, Thrombocytopenic, Idiopathic | 65 |
| Blood Coagulation Disorders | 1 |
| Bronchiolitis Obliterans Syndrome | 1 |
| Connective Tissue Diseases | 1 |
| Thrombocytopenia | 1 |
Trials
Showing 1 to 25 of 65. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.